期刊文献+

抗HER2单链抗体融合凋亡蛋白对SKOV3细胞的靶向杀伤 被引量:5

Expression of a secreted fusion protein consisting of anti-HER2 antibody and reversed caspase-3 and its suppression on growth of SKOV3 cells
下载PDF
导出
摘要 目的 :探讨分泌表达的抗HER2单链抗体与重构型人caspase 3融合蛋白对HER2抗原阳性肿瘤细胞的靶向杀伤作用。方法 :将重构型人caspase 3基因亚克隆入pCMV e2 3scFv PEII PEIII的相应位点 ,构建重组真核表达载体 pCMV e2 3scFv PEII revcasp3,并转染人T淋巴瘤细胞系Jurkat,筛选并建系。用ELISA检测培养上清中融合蛋白的分泌表达。通过共培养实验观察含有该融合蛋白的培养上清对人卵巢癌细胞SKOV3生长的抑制作用。结果 :融合蛋白基因可在Jurkat细胞中 ,分泌表达并杀伤SKOV3细胞。结论 :分泌表达的抗erbB2单链抗体与重构型人caspase AIM: To investigate the killing effect on SKOV3 cells by fusion protein HER2 specific antibody reversed caspase 3 in the secreted form. METHODS: The reversed human caspase 3 gene was subcloned into pCMV e23scFv PEII PEIII to construct recombinant eukaryotic expression vector pCMV e23scFv PEII revcasp 3 and transfect Jurkat cells. The secreted expression of the in culture supernant of transfected Jurkat cells was detected by ELISA. The suppression of the fusion protein on growth of SKOV3 cells was examined by co culture with supernant of transfected Jurkat cells. RESULTS: There was the secreted expression of the fusion protein in Jurkat cells. Expressed product had the activity of inducing SKOV3 cells to death. CONCLUSION: The fusion protein expressed in the secreted form can targeted towards SKOV3 cells and kill them.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2003年第2期160-162,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家高技术发展计划 (863)资助项目 (No.2 0 0 1AA2 1 71 0 1 ) 国家杰出青年科学基金资助项目 (No.399Z50 36) 军队杰出中青年人才基金资助项目 (No .98J0 0 9)
关键词 天冬氨酸特异性半胱氨酸蛋白酶 单链抗体 表皮生长因子受体 HER-2 肿瘤 SKOV3细胞 靶向杀伤作用 reversed caspase 3 HER2 secreted expression targeted cytotoxicity
  • 相关文献

参考文献2

二级参考文献17

  • 1Thornberry NA, Lazebnik Y. Caspase: enemies within.Science,1998, 281:1312-1316.
  • 2Hengartner M. The biochemistry of apoptosis.Nature,2000, 407:770-776.
  • 3Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, A novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95(Fas/APO-1) death-inducing signaling complex.Cell,1996, 85: 817-827.
  • 4Muzio M, Salvesen GS, Dixit VM. FLICE induced apoptosis in a cell-free system. J Biol Chem,1997, 272:2952-2956.
  • 5Srinivasula SM, Ahmad M, Macfarlane M,et al. Generation of constitutively active recombinant caspase-3 and 6 by rearrangement of their subunits. J Biol Chem, 1998, 273:10107-10111.
  • 6Schneider P, Tschopp J. Apoptosis induced by death receptors.Pharm Acta Helv, 2000, 74:281-286.
  • 7Muzio M, Stockvell BR,Stennicke HR, et al. An induced promoximity model for caspase-8 activation.J Biol Chem, 1998, 273:2926-2930.
  • 8William W ,Kenneth AK, Ana MM, et al.The atomic-resolution structure of human caspase-8, a key activator of apoptosis.Structur Fold Des, 1999, 7:1135-1143.
  • 9Blanchard, Hand Grutter, MG. The three-dimensional structure of caspase-8: an inhibitor enzyme in apoptosis.Structure,1999, 7:1125-1143.
  • 10Robert M, Horton D, Steffon H, et al. Engineering hybrid genes without the use of restriction enzyme: gene splicing by overlap extension. Gene, 1989, 77:61-63.

共引文献24

同被引文献29

  • 1王芳,裘秀春,王立锋,许彦鸣,赵晶,孟艳玲,贾林涛,王成济,范清宇,杨安钢.重组抗HER2 ScFv/tbid基因的表达及其对乳腺癌SKBr-3细胞的促凋亡作用[J].第四军医大学学报,2006,27(12):1057-1059. 被引量:1
  • 2Baxevanis CN,Sotiropoulou PA,Sotiriadou NN,et al.Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy[J].Cancer Immunol Immunother,2004,53(3):166-175.
  • 3Zhou H,Randall RL,Brothman AR,et al.Her-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification[J].J Pediatr Hematol Oncol,2003,25(1):27-32.
  • 4Morris CD,Gorlick R,Huvos G,et al.Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma[J].Clin Orthop Relat Res,2001,(382):59-65.
  • 5Ross JS,Fletcher JA.The HER-2/neu oncogene:prognostic factor,predictive factor and target for therapy[J].Semin Cancer Biol,1999,9(2):125-138.
  • 6Salmon DJ,Clark GM,Wong SG,et al.Human breast cancer:correlation of relapse and survival with amplification of the HER2/neu oncogene[J].Science,1987,235(4785):177-182.
  • 7Li X,Stuckert P,Bosch L,et al.Single chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cell[J].Cancer Gene Ther,2001,8(8):555-565.
  • 8Tsai YS,Shiau AL,Chen YF,et al.Enhancement of antitumor activity of gammaretrovirus carrying IL-12 gene through genetic modification of envelope targeting HER2 receptor:a promising strategy for bladder cancer therapy[J].Cancer Gene Ther,2010,17(1):37-48.
  • 9Tse C,Brault D,Gligorov J,et al.Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients[J].Clin Chem,2005,51(7):1093-1101.
  • 10Hynes NE, Stem DF. The biology of p185/neu/HER2 and its role in cancer [J]. Biochem Bioohys Acta, 1994, 1198: 165 - 170.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部